NO
|
Sesi
|
Keyword
|
Kode
|
Judul
|
151
|
Bayside Auditorium B
|
Estimating the Effect of Disruptive Technologies and Policies in the US Healthcare Market
|
Economics evaluations and methods; Private sector in universal health coverage era;
|
152
|
Bayside Auditorium A
|
The Effect of Migration on Health, Health Insurance, and Health Behaviors
|
Non communicable diseases, tobacco and nutrition; Equity and equality
|
153
|
Bayside Terrace
|
Affordable Care Act Policies to Expand Coverage: Evidence Public Sector, Employer-Sponsored, and Individual and Small Group Markets
|
Health care policy; Health care reform; Universal health coverage
|
154
|
Bayside 103
|
An Evolutionary Tale of Five Preference-Weighted Health State Utility Measures
|
Economic evaluation and methods
|
155
|
Bayside 104
|
Advances in Discrete Choice Experiments among National Policy Makers: Eliciting Equity-Efficiency Preferences in Health
|
Discrete Choice Experiments; Health providers and patient choice
|
156
|
Bayside 204A
|
Methodological Challenges for Estimating Health Service Delivery Costs in Low-Income Settings
|
Service delivery, access and healthcare utilization; Economics evaluations and methods; Costs of care
|
157
|
Bayside 204B
|
Physician-Patient Interaction in the Pharmaceutical Market
|
Pharmaceutical and subtances; Patient behavior and behavioral economics
|
158
|
Bayside 102
|
Financial Incentives in Health: Evidence from India’s Janani Suraksha Yojana
|
Health financing; Quality of care; Service delivery, access and healthcare utilization; Maternal and child health
|
159
|
Bayside 105
|
Does Price Discrimination have a Place in Pharmaceutical Pricing in Developing Countries?
|
Pharmaceutical and subtances; Economic evaluations and methods
|
160
|
Bayside 109
|
Economics of Cannabis Use
|
Pharmaceutical and subtances; Economic evaluations and methods
|
161
|
Bayside 201
|
Pricing, Promotion and Obesity: Implications for Taxation and Regulatory Policies
|
Non communicable diseases, tobacco and nutrition;
|
162
|
Bayside 202
|
The Costs and Provision of ART Care Across Three Developing Countries
|
Quality of care; Costs of care
|
163
|
Bayside 203
|
Analysing Unexplained Variations in Performance to Increase the Efficiency of Health Care: Case Studies from the ECHO Project
|
Economic evaluations and methods; Quality of care
|
164
|
Bayside 106
|
Measuring Universal Health Coverage: Health Service Utilization and the Financial Burden of Health Payments in Asia
|
Universal health coverage; Service delivery, access and health care utilization; Health financing
|
165
|
Bayside 101
|
India: Quality, Accountability, and Financing Reform
|
Quality of care
|
166
|
Bayside Auditorium B
|
The Origins of Health Economics: Some Reflections on Early Contributors to Health Economic Thought
|
Economics evaluations and methods; Equity and equility
|
167
|
Bayside Auditorium A
|
Health Equity and Financial Protection in Asia Impacts of Health Insurance Reform in Four Countries
|
Equity and equality; Health financing; Maternal and child health; Universal health coverage
|
168
|
Bayside Terrace
|
Use of Discrete Choice Experiments to Elicit End-of-Life Health Care Attitudes and Preferences
|
Discrete Choice Experiments
|
169
|
Bayside 103
|
Networks in Health Economics
|
Economic evaluations and methods; Private sector in universal health coverage era; Health policy
|
170
|
Bayside 104
|
Breaking the Addiction to Adoption in Health Economics: Perspectives from Australia, Scotland, Canada and England
|
Quality of care; Health care reform
|
171
|
Bayside 204A
|
Guidelines for Choosing the Appropriate Technique for Multi-Criteria Decision Analysis in Health Care
|
Health policy
|
172
|
Bayside 204B
|
Physician Incentives: Evidence from East Asia
|
Health professions; Patient behavior and behavioral economics
|
173
|
Bayside 102
|
The Broader Economic Impact of Vaccination in Low and Middle Income Countries: Fiscal Space Related Issues
|
Communicable diseases, HIV/AIDS, and vaccines; Health financing
|
174
|
Bayside 105
|
Coverage, Value, and Sustainability of Micro Health Insurance on the Indian Subcontinent
|
Universal health coverage; Service delivery, access and health care utilization
|
175
|
Bayside 109
|
Incentives for Safe Sex: Evaluating Economic Incentives as a Prevention Strategy for HIV and other Sexually Transmitted Infections (STIs)
|
Communicable diseases, HIV/AIDS, and vaccines; Economics evaluations and methods
|
176
|
Bayside 201
|
Dental Health Economics
|
Service delivery, access and healthcare utilization; Economics evaluations and methods; Health financing
|
177
|
Bayside 202
|
Efficiency Measurement Incorporating Quality: Exploring New Methodological Approaches
|
Quality of care; Health care reform
|
178
|
Bayside 203
|
Analytical Advancements in Measuring Development Assistance for Health
|
Health policy; Health financing
|
179
|
Bayside 106
|
Risky Behaviors and Human Capital
|
Impact of health status; Mental health and elderly health issues; Pharmaceutical and subtances;
|
180
|
Bayside 101
|
What Can Myanmar Learn from its Neighbours as it Starts its Journey to Achieve Universal Health Coverage?
|
Universalh health coverage; Health financing
|
181
|
Bayside Auditorium B
|
What is the Impact of Health Status
|
Impact of health status
|
182
|
Bayside Auditorium A
|
What Affects Access to Care
|
Service delivery, access, and health care utilization; Patient behavior and behavioral economics; Equity and equality
|
183
|
Bayside Terrace
|
Economic Evaluation of Screening
|
Economic evaluations and methods; Costs of care
|
184
|
Bayside 103
|
Health Status & Methodology
|
Impact of health status; Mental health and elderly health issues
|
185
|
Bayside 104
|
Access to Care
|
Service delivery, access and health care utilization; Health providers and patient choice; Universal Health Coverage; Equity and equality
|
186
|
Bayside 204A
|
Allied and Informal Health Providers
|
Health professions; Health providers and patient choices; Quality of care; Maternal and child health
|
187
|
Bayside 204B
|
Impact of Technology
|
Quality of care
|
188
|
Bayside 102
|
Economic Evaluation of Programmes II
|
Economic evaluations and methods; Costs of care
|
189
|
Bayside 105
|
Equity & Inequality Issues
|
Equity and equility; Universal health coverage
|
190
|
Bayside 109
|
Health Insurance for the Poor
|
Universal health coverage; Health financing; Equity and equality
|
191
|
Bayside 201
|
Universal Health Care
|
Universal health care; Equity and equality
|
192
|
Bayside 202
|
Issues in Hospitals
|
Hospital and hospital management; Health care reform; Quality of care
|
193
|
Bayside 203
|
Issues in Drug Costing
|
Pharmaceutical and subtances; Health policy; Economics evaluations and methods
|
194
|
Bayside 106
|
Utilization
|
Cost of care; Quality of care; Service delivery, access and health care utilization;
|
195
|
Bayside 101
|
Economics of Smoking
|
Non-communicable disease, tobacco and nutrition; Economic evaluation and methods
|
196
|
Bayside Auditorium B
|
Hospital Payments
|
Hospital and hospital management; Economic evaluations and methods; Quality of care
|
197
|
Bayside Auditorium A
|
Physician Supply
|
Health professions; Health policy
|
198
|
Bayside Terrace
|
Economic Burden of Illness
|
Non-communicable disease, tobacco and nutrition; Economic evaluation and methods
|
199
|
Bayside 103
|
Prescribing Behaviour
|
Health professions; Pharmeceutical and subtances; Costs of care
|
200
|
Bayside 104
|
The Impact of Out-of-Pocket Payments
|
Economic evaluations and methods; Equity and equality; Health financing
|
201
|
Bayside 204A
|
Effect of Health Expenditure
|
Health care financing; Service delivery, access and health care utilization
|
202
|
Bayside 204B
|
Cost of Health Care
|
Costs of care
|
203
|
Bayside 102
|
Issues in Tele-Health
|
Health policy; Health reform; Economic evaluations and methods
|
204
|
Bayside 105
|
Economics of Obesity II
|
Non-communicable disease, tobacco and nutrition; Economic evaluation and methods
|
205
|
Bayside 109
|
Health Care Reform
|
Health care refrom
|
206
|
Bayside 201
|
Improving Hospital Care
|
Hospital and hospital management; Quality of care
|
207
|
Bayside 203
|
Immunization Economics
|
Economics evaluation and methods; Service delivery, access, and health care utilization; Non-communicable disease, tobacco, and nutrition
|
208
|
Bayside 106
|
Policy Intervention
|
Cost of care; Health policy
|
209
|
Bayside 101
|
Treatment Compliance
|
Cost of care
|
210
|
Bayside Auditorium B
|
Applications of Willingness-To-Pay
|
Patient behavior and behavioral economics; Health providers and patient choice
|
211
|
Bayside Auditorium A
|
Insurance in Developing Markets
|
Universal health coverage; Service delivery, access, and health care utilization
|
212
|
Bayside Terrace
|
Taxation Policy
|
Economic evaluations and methods
|
213
|
Bayside 103
|
Early Child Health
|
Maternal and child health; Economic evaluations and methods
|
214
|
Bayside 104
|
Paying Doctors
|
Health financing
|
215
|
Bayside 204A
|
Assessing Health Status
|
Economic evaluations and methods
|
216
|
Bayside 204B
|
Issues in Out-of-Pocket Payments
|
Health financing; Health policy
|
217
|
Bayside 102
|
Assessing Prevention Programs
|
Economic evaluation; Quality of care; Health provider and patient choice
|
218
|
Bayside 105
|
Subsidizing Insurance
|
Service delivery, access and health care utilization; Health providers and patient choice
|
219
|
Bayside 109
|
What Affects Health II
|
Health status impact; Equity and equality
|
220
|
Bayside 201
|
Economic Evaluation II
|
Discrete choice experiments; Economic evaluations and methods
|
221
|
Bayside 202
|
Health Care Utilization
|
Service delivery, access and health care utilization; Maternal and child health
|
222
|
Bayside 203
|
Public Health Policy
|
Health policy; Health reform; Costs of care
|
223
|
Bayside 106
|
Provider Issues
|
Health providers and patient choice; Health professions
|
224
|
Bayside 101
|
Methodological Issues
|
Economic evaluations and methods; Health policy
|
225
|
TBA
|
ePoster Session
|
Non-communicable diseases, HIV/AIDS, and vacciness; Economic evaluations and methods; Cost of care; Health professions; Discrete choice experiments; Mental health and elderly health issues; Pharmaceutical and subtances; Health policy
|